JCAR17 | BMY Message Board Posts

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1123 of 1496  at  12/7/2019 4:39:37 PM  by

stockmd


 In response to msg 1120 by  cptspr
view thread

Re: JCAR17

My understanding is that the continued low incidence of CRS and neuropathy associated with JCAR17 would support outpatient administration, which would be a big advantage for patients, the healthcare system and insurers.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 8     Views: 239
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...